We are live on ! Find out more
Federated Hermes

Federated Hermes Portfolio holdings

AUM $61.5B
1-Year Est. Return 30.7%
This Fund
S&P 500
This Quarter Est. Return
-16.48%
1 Year Est. Return
+30.7%
3 Year Est. Return
+96.89%
5 Year Est. Return
+121.97%
10 Year Est. Return
+542.41%
AUM
$34B
AUM Growth
-$10.9B
Cap. Flow
-$1.34B
Cap. Flow %
-3.93%
Top 10 Hldgs %
18.63%
Holding
2,452
New
252
Increased
885
Reduced
1,004
Closed
226

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$213M
2
UPS icon
United Parcel Service
UPS
+$148M
3
CSCO icon
Cisco
CSCO
+$117M
4
UL icon
Unilever
UL
+$110M
5
MRNA icon
Moderna
MRNA
+$108M

Top Sells

Rank Stock Value
1
VTR icon
Ventas
VTR
+$345M
2
LYB icon
LyondellBasell Industries
LYB
+$245M
3
OXY icon
Occidental Petroleum
OXY
+$191M
4
AMCR icon
Amcor
AMCR
+$190M
5
WELL icon
Welltower
WELL
+$127M

Sector Composition

Rank Sector Weight
1 Healthcare 22.41%
2 Technology 16.17%
3 Consumer Discretionary 10.06%
4 Financials 9.96%
5 Communication Services 8.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SVRA icon
2151
Savara
SVRA
$1.08B
$1K ﹤0.01%
261
+107
+69% +$293
THRM icon
2152
Gentherm
THRM
$1.32B
$1K ﹤0.01%
15
TRNS icon
2153
Transcat
TRNS
$760M
$1K ﹤0.01%
+42
New +$1.26K
TWI icon
2154
Titan International
TWI
$492M
$1K ﹤0.01%
+718
New +$1.84K
TZOO icon
2155
Travelzoo
TZOO
$76.7M
$1K ﹤0.01%
+39
New +$343
UBS icon
2156
UBS Group
UBS
$170B
$1K ﹤0.01%
+160
New +$1.84K
UTI icon
2157
Universal Technical Institute
UTI
$2.26B
$1K ﹤0.01%
218
+134
+160% +$949
VRCA icon
2158
Verrica Pharmaceuticals
VRCA
$89M
$1K ﹤0.01%
4
-1,728
-100% -$227K
VRDN icon
2159
Viridian Therapeutics
VRDN
$2.2B
$1K ﹤0.01%
+92
New +$1.07K
WATT icon
2160
Energous
WATT
$71.8M
0
WTI icon
2161
W&T Offshore
WTI
$525M
$1K ﹤0.01%
388
-135
-26% -$460
TBRG
2162
DELISTED
TruBridge
TBRG
$1K ﹤0.01%
+48
New +$1.23K
SEI
2163
Solaris Energy Infrastructure
SEI
$2.66B
$1K ﹤0.01%
+65
New +$682
EVBN
2164
DELISTED
Evans Bancorp Inc
EVBN
$1K ﹤0.01%
+21
New +$742
ENZ
2165
DELISTED
Enzo Biochem, Inc.
ENZ
$1K ﹤0.01%
297
LUMO
2166
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$1K ﹤0.01%
102
-57
-36% -$797
ASXC
2167
DELISTED
Asensus Surgical, Inc.
ASXC
$1K ﹤0.01%
1,674
+1,106
+195% +$1.16K
SBOW
2168
DELISTED
SilverBow Resources, Inc.
SBOW
$1K ﹤0.01%
+326
New +$1.6K
KAMN
2169
DELISTED
Kaman Corp
KAMN
$1K ﹤0.01%
1
EIGR
2170
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$1K ﹤0.01%
+6
New +$1.91K
EXPR
2171
DELISTED
Express, Inc.
EXPR
$1K ﹤0.01%
35
-329
-90% -$24.1K
SFE
2172
DELISTED
Safeguard Scientifics, Inc.
SFE
$1K ﹤0.01%
264
-79
-23% -$706
SRT
2173
DELISTED
Startek Inc.
SRT
$1K ﹤0.01%
+210
New +$1.41K
NETI
2174
DELISTED
Eneti Inc.
NETI
$1K ﹤0.01%
45
+13
+41% +$480
VRTV
2175
DELISTED
VERITIV CORPORATION
VRTV
$1K ﹤0.01%
+126
New +$1.6K

Similar funds

Federated Hermes's Q1 2020 Portfolio in Review

As of Q1 2020, Federated Hermes held 2,452 positions worth $34B, down 24% from $44.9B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Federated Hermes withdrew a net $1.34B in Q1 2020, closing 226 positions and reducing 1,004 holdings. Its most notable exit was Air Lease Corp, an estimated $102M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Federated Hermes opened a new position in Apollo Global Management worth $42.2M.

  • Federated Hermes's largest Q1 2020 buy was Apollo Global Management: 1,259,792 shares worth $42.2M.
  • Federated Hermes added most to Merck in Q1 2020, an estimated $213M increase.
  • Federated Hermes's biggest Q1 2020 reduction was Ventas, cutting an estimated $345M.
  • Federated Hermes fully exited Air Lease Corp in Q1 2020, selling an estimated $102M.
  • Federated Hermes's ten largest holdings make up 19% of its $34B portfolio in Q1 2020.
  • Federated Hermes opened 252 new positions and closed 226 in Q1 2020.
  • Federated Hermes's portfolio value fell 24% quarter-over-quarter to $34B.

Based on Federated Hermes's 13F filing for Q1 2020, filed 13 May 2020.